Director and PDMR share purchase

RNS Number : 1541F
IXICO plc
11 July 2019
 

11 July 2019

 

IXICO plc

("IXICO" or the "Company")

 

Director and PDMR share purchase

IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that it received notification on 10 July 2019 that on 05 July 2019 and 09 July 2019 Charles Spicer, Chairman of the Company, acquired 140,421 ordinary shares at an average price of 28.485p.

 

Charles Spicer is interested in 333,196 Ordinary Shares, representing 0.71 per cent of the enlarged issued share capital of the Company following the purchase.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Charles Spicer

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chairman

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

IXICO plc

b)

 

LEI

 

 

2138005M1F59O6HWSA97

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares in IXICO plc



Identification code

GB00BCLY7L40

 


b)

 

Nature of the transaction

 

 

Acquisition

c)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

5/7/19

 

 


 

29.499p

33,899

 


 

29p

34,482

 


 

29p

34,482

 


 

9/7/19

 

 


 

26.625p

37,558

 


 

 

 

 

d)

 

Aggregated information




- Aggregated volume

140,421 shares



- Price

28.485p



e)

 

Date of the transaction

 

 

5/7/19 and 9/7/19

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market (IXI), UK

 

IXICO plc

+44 (0) 20 3763 7498

Giulio Cerroni, Chief Executive Officer




Cenkos Securities PLC (Nominated adviser and sole broker)

+44 (0) 20 7397 8900

Giles Balleny / Max Gould (Corporate Finance)


Michael F Johnson / Russell Kerr (Sales)




Optimum Strategic Communications

 +44 (0) 203 950 9144

Mary Clark / Anne Marieke Ezendam / Supriya Mathur


ixico@optimumcomms.com


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHURVNRKOABAAR

Companies

Ixico (IXI)
UK 100

Latest directors dealings